Galapagos | GLPG - Nettoeinkommen

Aktienkurs
27.82
Täglich Wechseln
0.14 0.51%
Monatlich
-5.89%
Jährlich
15.72%
Q1 Prognose
27.00




Nettoeinkommen Veränderung Datum
argenx SE USD 532.95M 188.69M 2025-12
AstraZeneca USD 2.33B 207M 2025-12
Biogen USD 466.5M 168.3M 2025-09
Genmab DKK 31M 370M 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
GRIFOLS EUR 98.25M 28.72M 2025-12
Hikma Pharmaceutical USD 164M 45M 2025-12
Incyte USD 299.28M 124.89M 2025-12
Merck EUR 319M 583M 2025-12
Neurocrine Biosciences USD 209.5M 102M 2025-09
Novartis USD 2.41B 1.52B 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR -801M 3.6B 2025-12
UCB EUR 1.08B 608M 2025-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12